INDV vs. BBIO
INDV (Indivior PLC Ordinary Shares) and BBIO (BridgeBio Pharma, Inc.) are both stocks. Both are in the Healthcare sector — INDV in Drug Manufacturers - Specialty & Generic, BBIO in Biotechnology. Over the past 5 years, INDV returned 74.21%/yr vs 1.89%/yr for BBIO. At a 0.06 correlation, their price movements are largely independent.
Performance
INDV vs. BBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INDV achieves a 4.21% return, which is significantly higher than BBIO's -11.92% return.
INDV
- 1D
- -0.60%
- 1M
- -5.34%
- YTD
- 4.21%
- 6M
- 2.16%
- 1Y
- 165.74%
- 3Y*
- 21.26%
- 5Y*
- 74.21%
- 10Y*
- 28.52%
BBIO
- 1D
- -0.35%
- 1M
- -0.03%
- YTD
- -11.92%
- 6M
- -9.25%
- 1Y
- 74.44%
- 3Y*
- 61.48%
- 5Y*
- 1.89%
- 10Y*
- —
INDV vs. BBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
INDV Indivior PLC Ordinary Shares | 4.21% | 188.66% | -18.60% | -29.79% | 530.43% | 135.49% | 181.73% | 1.82% |
BBIO BridgeBio Pharma, Inc. | -11.92% | 178.75% | -32.03% | 429.79% | -54.32% | -76.54% | 102.88% | 27.22% |
Correlation
The correlation between INDV and BBIO is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2019 | 0.06 |
The correlation between INDV and BBIO shifts across timeframes, from 0.06 (all time) to 0.25 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
INDV:
$4.82B
BBIO:
$13.12B
INDV:
$1.98
BBIO:
-$3.76
INDV:
3.69
BBIO:
23.00
INDV:
$1.29B
BBIO:
$566.04M
INDV:
$1.05B
BBIO:
$538.20M
INDV:
$362.00M
BBIO:
-$602.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INDV vs. BBIO — Risk / Return Rank
INDV
BBIO
INDV vs. BBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Indivior PLC Ordinary Shares (INDV) and BridgeBio Pharma, Inc. (BBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| INDV | BBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.55 | ||
| Sortino ratioReturn per unit of downside risk | +3.17 | ||
| Omega ratioGain probability vs. loss probability | 1.64 | 1.30 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 7.81 | 3.70 | +4.11 |
| Martin ratioReturn relative to average drawdown | 22.50 | 9.25 | +13.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| INDV | BBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.15 | 1.60 | +2.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.40 | 0.02 | +0.38 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.16 | +0.05 |
Drawdowns
INDV vs. BBIO - Drawdown Comparison
The maximum INDV drawdown since its inception was -93.82%, roughly equal to the maximum BBIO drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for INDV and BBIO.
Loading charts...
Drawdown Indicators
| INDV | BBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.82% | -92.80% | -1.02% |
Max Drawdown (1Y)Largest decline over 1 year | -21.37% | -20.25% | -1.12% |
Max Drawdown (3Y)Largest decline over 3 years | -69.89% | -49.08% | -20.81% |
Max Drawdown (5Y)Largest decline over 5 years | -69.89% | -91.89% | +22.00% |
Max Drawdown (10Y)Largest decline over 10 years | -93.82% | — | — |
Current DrawdownCurrent decline from peak | -7.93% | -15.69% | +7.76% |
Average DrawdownAverage peak-to-trough decline | -38.17% | -45.80% | +7.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.41% | 8.07% | -0.66% |
Volatility
INDV vs. BBIO - Volatility Comparison
The current volatility for Indivior PLC Ordinary Shares (INDV) is 10.49%, while BridgeBio Pharma, Inc. (BBIO) has a volatility of 12.10%. This indicates that INDV experiences smaller price fluctuations and is considered to be less risky than BBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INDV | BBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.49% | 12.10% | -1.61% |
Volatility (6M)Calculated over the trailing 6-month period | 25.73% | 34.41% | -8.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.22% | 46.75% | -6.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 186.80% | 85.95% | +100.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 149.39% | 83.80% | +65.59% |
Dividends
INDV vs. BBIO - Dividend Comparison
Neither INDV nor BBIO has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBIO BridgeBio Pharma, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
INDV Indivior PLC Ordinary Shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.68% | 1.18% |
Financials
INDV vs. BBIO - Financials Comparison
This section allows you to compare key financial metrics between Indivior PLC Ordinary Shares and BridgeBio Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INDV vs. BBIO - Profitability Comparison
INDV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Indivior PLC Ordinary Shares reported a gross profit of 277.00M and revenue of 317.00M. Therefore, the gross margin over that period was 87.4%.
BBIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a gross profit of 178.39M and revenue of 180.60M. Therefore, the gross margin over that period was 98.8%.
INDV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Indivior PLC Ordinary Shares reported an operating income of 137.00M and revenue of 317.00M, resulting in an operating margin of 43.2%.
BBIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported an operating income of -105.96M and revenue of 180.60M, resulting in an operating margin of -58.7%.
INDV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Indivior PLC Ordinary Shares reported a net income of 89.00M and revenue of 317.00M, resulting in a net margin of 28.1%.
BBIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BridgeBio Pharma, Inc. reported a net income of -164.04M and revenue of 180.60M, resulting in a net margin of -90.8%.
Frequently Asked Questions
INDV and BBIO have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBIO has higher volatility (12.10%) compared to INDV (10.49%). In terms of maximum drawdown, INDV dropped -93.82% vs BBIO's -92.80%.
INDV currently has the higher Sharpe Ratio (4.15 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INDV and BBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer